GGrantIndex
Sort

1,049,261 grants matching t cell

COG NCTN Network Group Operations Center - Year 10 STAR Act COG) Outcomes & Survivorship (LTE) Committee

$3,243,049
Douglas S. Hawkins · Public Health Institute · U10 · FY2023 · CA

Genetic and Biochemical Approaches to Tyrosine Kinase and Lymphocyte Signaling

$3,242,965
Pamela Schwartzberg · National Institute Of Allergy And Infectious Diseases · ZIA · FY2020 · AI

High resolution longitudinal immune monitoring for elucidating immune aging dynamics

$3,242,451
Mark M Davis · Stanford University · P01 · FY2025 · AI

SHIV/HIV Env-Antibody Coevolution as a Guide to Iterative Vaccine Design

$3,242,287
George M Shaw · University Of Pennsylvania · P01 · FY2020 · AI

Methods for Epidemiology Studies

$3,242,232
Nilanjan Chatterjee · Division Of Cancer Epidemiology And Genetics · ZIA · FY2011 · CA

Mechanisms Of Synaptic Plasticity In The Adult And Developing Nervous System

$3,242,214
Serena M Dudek · National Institute Of Environmental Health Sciences · ZIA · FY2024 · ES

Eliciting neutralizing antibodies and B cell responses using novel HIV Env immunogens in non-human primates

$3,242,006
Richard Thomas Wyatt · Scripps Research Institute, The · P01 · FY2021 · AI

Bridging Antibody Fc-mediated Antiviral Functions Across Humans and Non-human Primates

$3,241,864
Georgia D Tomaras · Duke University · P01 · FY2017 · AI

South Dakota Biomedical Research Infrastructure Network

$3,241,731
Barbara E Goodman · University Of South Dakota · P20 · FY2016 · GM

Cancer Center Support Grant

$3,241,388
Douglas Yee · University Of Minnesota · P30 · FY2014 · CA

Center for the Epigenetics of Common Human Disease

$3,241,352
Andrew P Feinberg · Johns Hopkins University · P50 · FY2010 · HG

Novel Therapies of Chronic Allograft Dysfunction

$3,241,031
Mohamed H Sayegh · Brigham And Women'S Hospital · U01 · FY2007 · AI

Idaho INBRE Program

$3,240,905
Carolyn Hovde Bohach · University Of Idaho · P20 · FY2016 · GM

South Dakota Biomedical Research Infrastructure Network

$3,240,835
Barbara E Goodman · University Of South Dakota · P20 · FY2009 · RR

Therapy for Fuchs Endothelial Corneal Dystrophy

$3,240,155
Philip Sanderson · National Center For Advancing Translational Sciences · ZIA · FY2019 · TR

Therapy for Fuchs Endothelial Corneal Dystrophy

$3,240,155
Philip Sanderson · National Center For Advancing Translational Sciences · ZIA · FY2018 · TR

NEW, NON-COMPETITIVE AWARD TO SYNVITROBIO, INC. PROJECT TITLE: ''HIGH-THROUGHPUT CELL-FREE PROTEIN SYNTHESIS FOR RAPID BIOENERGY PATHWAY IMPROVEMENTS''

$3,240,000
Synvitrobio, Inc. · · FY2021 · Department of Energy

PHASE 1B/2 STUDY OF 177LU GIRENTUXIMAB PLUS CABOZANTINIB AND NIVOLUMAB IN TREATMENT-NAIVE PATIENTS WITH ADVANCED CLEAR CELL RCC

$3,239,994
The Univeristy Of Texas M.D. Anderson Cancer Center · · FY2022 · Defense Health Agency

Role of Retrotransposon Activity in Neurodegeneration and Alzheimer's Disease

$3,239,892
John M. Sedivy · Brown University · P01 · FY2023 · AG

Epidemiology and Natural History of Cancer-Associated Viruses

$3,239,380
Sam M Mbulaiteye · Division Of Cancer Epidemiology And Genetics · ZIA · FY2015 · CA

Human immune signatures of Dengue virus and Mycobacterium Tuberculosis exposure in infection, disease and vaccination

$3,238,555
Alessandro Sette · La Jolla Institute For Immunology · U19 · FY2017 · AI

Intervention Trials in Persons at Increased Genetic Risk of Cancer

$3,238,292
Mark H Greene · Cancer Epidemiology And Genetics · Z01 · FY2007 · CA

Tuberculosis Imaging Program

$3,238,062
Steven Holland · National Institute Of Allergy And Infectious Diseases · ZIC · FY2025 · AI

Cellular Immunity to Category A-C Viruses in Humans

$3,237,810
Alan L Rothman · Univ Of Massachusetts Med Sch Worcester · U19 · FY2010 · AI

Translational Program of Excellence in Nanotechnology

$3,236,405
Ralph Weissleder · Massachusetts General Hospital · U01 · FY2008 · HL